false 1 September 2023 OC413389 2023-09-01 2024-08-31 OC413389 2023-08-31 OC413389 2024-08-31 OC413389 frs102-bus:FRS102 2023-09-01 2024-08-31 OC413389 frs102-bus:LimitedLiabilityPartnershipLLP 2023-09-01 2024-08-31 OC413389 frs102-bus:FullAccounts 2023-09-01 2024-08-31 OC413389 frs102-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 OC413389 2022-09-01 2023-08-31 OC413389 2022-08-31 OC413389 2023-08-31 OC413389 frs102-core:CurrentFinancialInstruments 2024-08-31 OC413389 frs102-core:CurrentFinancialInstruments 2023-08-31 OC413389 frs102-core:Non-currentFinancialInstruments 2024-08-31 OC413389 frs102-core:Non-currentFinancialInstruments 2023-08-31 OC413389 frs102-bus:Director1 2023-09-01 2024-08-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number:
OC413389
Abby Pharma (U.K) LLP
Unaudited Accounts
for the Year Ended
31 August 2024


Abby Pharma (U.K) LLP
Balance Sheet
as at 31 August 2024

Notes 2024
£
2023
£
Current Assets
Debtors 2,049,866 2,292,902
Cash at bank and in hand 996,526 543,630
3,046,392 2,836,532
Creditors falling due within one year (1,395,619) (807,285)
Net Current Assets / (Liabilities) 1,650,773 2,029,247
Creditors falling due after more than one year (3,266) (4,004)
Net Assets Attributable to Members 1,647,507 2,025,243
Represented by:
Loans and other debts due to members within one year
Members' capital classified as a liability 3 1,539,129 1,916,865
1,539,129 1,916,865
.
Members' other interests
Members' capital classified as a equity 3 108,378 108,378
1,647,507 2,025,243
.
Total members' interests
Loans and other debts due to members 1,539,129 1,916,865
Members' other interests 108,378 108,378
1,647,507 2,025,243

Abby Pharma (U.K) LLP
Balance Sheet
as at 31 August 2024



These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The members have not delivered a copy of the LLP's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006 (as applied to LLPs).

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 (as applied to LLPs) with respect to accounting records and the preparation of accounts.

For the year ended 31 August 2024 the LLP was entitled to exemption under section 477 of the Companies Act 2006 (as applied to LLPs) relating to small LLPs.

The financial statements were approved by the members and signed on their behalf by:



.........................................................


Approved by members on 20 May 2025


Ultrasure Company Inc

Designated Member

Abby Pharma (U.K) LLP

Registered number: OC413389 (England and Wales)


Abby Pharma (U.K) LLP
Notes to the Accounts
for the year ended 31 August 2024

1. Accounting Policies

Basis of preparation

These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, the Companies Act 2006 and the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

These financial statements reflect the results of the LLP for the year ended 31 August 2024.

Turnover

Turnover represents amounts due in respect of legal services provided during the year, net of any indirect taxes.

Tax provisions

Taxation on the profits of the LLP is solely the liability of individual members. Therefore, neither income tax nor deferred tax arising in respect of the LLP's profit is included in these financial statements.
2. Employees
2024 2023
Average number of employees during the period 0 0

3. Members' Interests
Members capital classed as equity Other reserve Total
2024
Total
2023
£ £ £ £
Brought Forward 108,378 2,096,180 2,025,243 2,924,619
Profit (loss) for period available for discretionary
division among members
- (377,736) (377,736) (720,061)
Members' interest after profit (loss) for period 108,378 1,718,444 1,647,507 2,204,558
Other divisions of profits (losses) - - - -
Less: Drawings - - - (179,315)
Balance carried forward 108,378 1,718,444 1,647,507 2,025,243